Biotechnology French biopharma company Erytech Pharma, a company that designs innovative treatments for acute leukemia and other oncology indications with unmet medical needs, says that the French market regulator, AMF, granted its visa no13-166 on April 17, 2013, for the prospectus relative to the listing of Erytech shares on the NYSE Euronext regulated market in Paris. 21 April 2013